Clinical trial

An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in…

NCT00240851 · Johnson & Johnson Consumer and Personal Products Worldwide, Industry · Completed

Key facts

NCT number NCT00240851
Title An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in Treating Muscle Aches and Soreness That Occur After a Marathon Race
Official title A Randomized, Double-Blind, Placebo-Controlled Study Evaluating Acetaminophen Extended Release Caplets (3900 mg/Day) in the Treatment of Post-Race Muscle Aching and Pain (Soreness)
Lead sponsor Johnson & Johnson Consumer and Personal Products Worldwide, Industry
Collaborators McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Pain
Intervention type Drug
Interventions acetaminophen extended release
Enrollment 665
Completion Feb 1, 2004
First posted Oct 18, 2005
Last update posted Jun 19, 2015

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies